The eighth week of the inquest heard from toxicologists and anonymous witnesses who were asked about the memorialisation of ...

After a meeting with the FDA, the company believes the agency is aligned with its development plan to start a Phase III registrational trial in CLDN 18.2-, PD-L1-positive tumors.

Biomerica has received its first commercial order for Hp Detect(TM), from one of the largest clinical laboratory chains operating across Europe. -- Strategic Account: This new lab's scale and ...

Biomerica has received its first commercial order for Hp Detect™, from one of the largest clinical laboratory chains operating across ...

In the United States, the Shield MCD test has received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) based on its strong performance in predicting the presence of ...

MHRA registration authorizes hp+detect™ for commercial sale in Great BritainActive Commercialization: Biomerica is in active ...

Scientists at the Queensland University of Technology (QUT) in Australia have developed a new saliva test that could help doctors detect several types of cancer much earlier than before. The new ...

MHRA registration authorizes hp+detect(TM) for commercial sale in Great Britain -- Active Commercialization: Biomerica is in active discussions with UK partners to access the diagnostic laboratory ...

Gastric cancer (stomach cancer) develops when cells lining the inner surface of the stomach become cancerous and begin to grow uncontrollably. In Japan, it remains one of the most common types of ...

Introduction Dysphagia accounts for a large proportion of 2ww referrals for direct-to-test gastroscopy, but patients often receive no medical input or explanation for their symptoms. Additionally, ...